← Leaderboards
Victor Luis Villemagne
University Of Pittsburgh At Pittsburgh
$6,217,884
Attributed
$13,939,808
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.2M · FY2020–25$20M$15M$10M$5M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$36,633,672 · 6
By mechanism
P01$23,531,445 · 3
R01$7,556,152 · 2
RF1$5,546,075 · 1
Top collaborators
- Howard J Aizenstein10 shared
- Ann D. Cohen4 shared
- Sarah B Berman3 shared
- Milos D Ikonomovic3 shared
- Shaolin Yang3 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Howard J Aizenstein$23,319,766
- William E Klunk$26,129,826
- Jair C Soares$9,002,949
- Oscar L. Lopez$26,660,804
- Milos D Ikonomovic$11,868,106
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposBrainFunctional DisorderImpaired CognitionS DiseasePositron-Emission TomographyCohortImageParticipantCognitionNerve DegenerationAgingCerebrovascular DisordersIn VivoLinkS Disease PathologyDementiaNeuroimagingEvaluationTau ProteinsMagnetic Resonance ImagingPre-ClinicalAmyloid Beta-ProteinDeposition
Grant awards (13)
Brain mitochondrial PET imaging and 31P-MR spectroscopy to dissect the role of mitochondrial dysfunction in bioenergetic dysregulation in Dementia with Lewy Bodies pathogenesis$1,679,694
R01 · FY2025 · AG
Roles of Gray Matter Brain Aging and Small Vessel Disease in AD Pathophysiology$1,240,339
R01 · FY2025 · AG
The role of astrogliosis in aging and the pathological and clinical progression of Alzheimer's Disease$6,703,737
P01 · FY2024 · AG
Roles of Gray Matter Brain Aging and Small Vessel Disease in AD Pathophysiology$1,632,570
R01 · FY2024 · AG
Brain mitochondrial PET imaging and 31P-MR spectroscopy to dissect the role of mitochondrial dysfunction in bioenergetic dysregulation in Dementia with Lewy Bodies pathogenesis$1,569,417
R01 · FY2024 · AG
In vivo imaging of reactive astrogliosis along the Alzheimer's disease continuum$279,194
P01 · FY2024 · AG · contact PI
The role of astrogliosis in aging and the pathological and clinical progression of Alzheimer's Disease$6,932,984
P01 · FY2023 · AG
Brain mitochondrial PET imaging and 31P-MR spectroscopy to dissect the role of mitochondrial dysfunction in bioenergetic dysregulation in Dementia with Lewy Bodies pathogenesis$1,434,132
R01 · FY2023 · AG
In vivo imaging of reactive astrogliosis along the Alzheimer's disease continuum$279,193
P01 · FY2023 · AG · contact PI
The role of astrogliosis in aging and the pathological and clinical progression of Alzheimer's Disease$6,909,110
P01 · FY2022 · AG
In vivo imaging of reactive astrogliosis along the Alzheimer's disease continuum$279,194
P01 · FY2022 · AG · contact PI
Roles of Gray Matter Brain Aging and Small Vessel Disease in AD Pathophysiology$5,546,075
RF1 · FY2021 · AG
Imaging Pathophysiology in Aging and Neurodegeneration$2,148,033
P01 · FY2020 · AG